<DOC>
	<DOC>NCT00395551</DOC>
	<brief_summary>The purpose of this study is to determine whether ranibizumab is effective in the treatment of choroidal neovascularization secondary to causes other then wet macular-degeneration.</brief_summary>
	<brief_title>Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration.</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<mesh_term>Neovascularization, Pathologic</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>active choroidal neovascularization pregnancy,agerelated macular degeneration, current eye infection or recent eye surgery, participating in other eye studies</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>choroidal neovascularization</keyword>
	<keyword>Choroidal Neovascularization Not related to Age-Related Macular Degeneration</keyword>
</DOC>